PMC:7212965 / 69108-69586 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T163","span":{"begin":288,"end":293},"obj":"Body_part"}],"attributes":[{"id":"A163","pred":"fma_id","subj":"T163","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T130","span":{"begin":288,"end":293},"obj":"Body_part"}],"attributes":[{"id":"A130","pred":"uberon_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T344","span":{"begin":165,"end":173},"obj":"Disease"},{"id":"T345","span":{"begin":371,"end":379},"obj":"Disease"}],"attributes":[{"id":"A344","pred":"mondo_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A345","pred":"mondo_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T507","span":{"begin":1,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T508","span":{"begin":1,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"},{"id":"T509","span":{"begin":258,"end":260},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T510","span":{"begin":288,"end":293},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T511","span":{"begin":288,"end":293},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20512","span":{"begin":1,"end":3},"obj":"Chemical"},{"id":"T30406","span":{"begin":448,"end":450},"obj":"Chemical"},{"id":"T42091","span":{"begin":451,"end":454},"obj":"Chemical"},{"id":"T21401","span":{"begin":465,"end":474},"obj":"Chemical"},{"id":"T46897","span":{"begin":476,"end":478},"obj":"Chemical"}],"attributes":[{"id":"A10435","pred":"chebi_id","subj":"T20512","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"},{"id":"A78377","pred":"chebi_id","subj":"T30406","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A38430","pred":"chebi_id","subj":"T42091","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"},{"id":"A51882","pred":"chebi_id","subj":"T21401","obj":"http://purl.obolibrary.org/obo/CHEBI_16990"},{"id":"A32558","pred":"chebi_id","subj":"T46897","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T315","span":{"begin":371,"end":379},"obj":"Phenotype"},{"id":"T316","span":{"begin":384,"end":398},"obj":"Phenotype"},{"id":"T317","span":{"begin":438,"end":446},"obj":"Phenotype"}],"attributes":[{"id":"A315","pred":"hp_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A316","pred":"hp_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/HP_0002027"},{"id":"A317","pred":"hp_id","subj":"T317","obj":"http://purl.obolibrary.org/obo/HP_0002013"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-sentences","denotations":[{"id":"T586","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T587","span":{"begin":91,"end":148},"obj":"Sentence"},{"id":"T588","span":{"begin":149,"end":208},"obj":"Sentence"},{"id":"T589","span":{"begin":209,"end":273},"obj":"Sentence"},{"id":"T590","span":{"begin":274,"end":328},"obj":"Sentence"},{"id":"T591","span":{"begin":329,"end":399},"obj":"Sentence"},{"id":"T592","span":{"begin":400,"end":478},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2245","span":{"begin":209,"end":217},"obj":"Species"},{"id":"2422","span":{"begin":165,"end":173},"obj":"Disease"},{"id":"2423","span":{"begin":371,"end":379},"obj":"Disease"},{"id":"2424","span":{"begin":384,"end":398},"obj":"Disease"},{"id":"2425","span":{"begin":438,"end":446},"obj":"Disease"}],"attributes":[{"id":"A2245","pred":"tao:has_database_id","subj":"2245","obj":"Tax:9606"},{"id":"A2422","pred":"tao:has_database_id","subj":"2422","obj":"MESH:C000657245"},{"id":"A2423","pred":"tao:has_database_id","subj":"2423","obj":"MESH:D003967"},{"id":"A2424","pred":"tao:has_database_id","subj":"2424","obj":"MESH:D015746"},{"id":"A2425","pred":"tao:has_database_id","subj":"2425","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Li, 202056The Second Affiliated Hospital of Chongqing Medical University, ChongqingDates: 1/2020-2/2020Last follow-up: n = 83Survival: NRInclusion: Inpatients with COVID-19 and at least one abnormal CT scan. Patients with normal CT were excluded (8).Age: m 45 ± 12.3 ySex: 47% femalesGI/liver comorbidities: NRDisease severity: 69.9% ordinary, and 30.1% severe/critical Diarrhea and abdominal pain: 8.4% (7)Present on admissionNausea or vomiting: NR AST, ALT, and bilirubin: NR"}